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Abstract
This commentary presents the proceedings of the symposium sponsored by Cardiovascular Section of American Physiological Society in San Diego, CA on 12 April 2003. The major focus of this symposium was on the actions and physiological relevance of several novel Ca 2+ signalling mechanisms in vascular smooth muscle (VSM) cells. Five important topics were presented in this symposium including the discovery and roles of cyclic ADP-ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP) in mediating Ca 2+ release, Ca 2+ sparks and activation of plasma membrane K Ca channels in VSM cells, the role of cADPR-mediated activation of ryanodine receptors in the control of vascular tone, the role of [Ca 2+ ] i in mechanotransduction in the arterioles, and interactions of mitochondrial Ca 2+ release and SR Ca 2+ mobilization. The purpose of this symposium was to promote discussions and exchange of ideas between scientists with interests in Ca 2+ signalling mechanisms and those with interests in vascular physiology and pharmacology. The cross-fertilization of ideas is expected to greatly advance our understanding of the physiological and pharmacological relevance of these new Ca 2+ signalling mechanisms.
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It is well known that changes in cytoplasmic Ca 2+ concentration ([Ca 2+ ] i ) play a critical role in activation of vascular smooth muscle (VSM) (Nelson et al. 1990 , Berridge 1994 , Himpens et al. 1995 . Previous studies have shown that these Ca through Ca 2+ channels in the plasma membrane (PM) and release of Ca 2+ from the sarcoplasmic reticulum (SR) through IP 3 receptors (IP 3 R) and ryanodine receptors (RyR) (Nelson et al. 1990 . A great deal of heterogeneity exists with respect to the participation of the various Ca 2+ influx and release channels dependent on which specific blood vessel and agonist are involved. Thus, noradrenaline, angiotensin II (Ang II), vasopressin (ADH), endothelin (ET), thromboxane A 2 appear to induce Ca 2+ release mainly by the opening of IP 3 R (Nelson et al. 1990 , Fasolato et al. 1994 , Petersen 1996 , while acetylcholine (Ach), prostaglandin F 2a and Ca 2+ activate predominantly RyR.
Caffeine opens RyR and inhibits IP 3 R (Galione & Sethi 1996) . The novel Ca 2+ mobilizing second messenger cyclic ADP-ribose (cADPR) appears to play an important role in the control of vascular tone through the activation of RyR (Kannan et al. 1997 , Yu et al. 2000 . Most interestingly, the spatio-temporal characteristics of the Ca 2+ signals determine their Acta Physiol Scand 2003, 179, 339-352 Ó 2003 Scandinavian Physiological Society functional outcomes. The sparks induced by spontaneous opening of clusters of RyR lead to relaxation, while Ca 2+ waves are mediated by regenerative activation or IP 3 R signal vasoconstriction. One of the unsolved mysteries is how resistance arteries sense pressure and respond to it with myogenic tone. Recent studies have demonstrated the critical role of integrin receptors in mediating mechanotransduction in the arterioles , Lee et al. 2002a ). All these mechanisms, which are emerging as fundamental to the regulation of vasomotion were the focus of this symposium.
Discovery and Ca 2+ release action of cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate (H. C. Lee, University of Minnesota)
Discovery of cADPR and NAADP
Cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate (NAADP) were first identified in sea urchin eggs, which has long been a favourite model for investigating Ca 2+ signalling mechanisms in cells (Clapper et al. 1987 , Lee et al. 1989 . A rather dramatic Ca 2+ wave occurs at fertilization.
Immediately after sperm-egg fusion, a small and localized flush of Ca 2+ occurs in the cortical region of the egg, which is followed shortly by a spark of Ca 2+ starting at the site of sperm-egg fusion and propagating as a Ca 2+ wave across the entire egg. The consequence of this Ca 2+ wave is the activation of cortical exocytosis, resulting in the formation of the fertilization membrane that begins at the fusion site and eventually surrounds the whole egg. The source of Ca 2+ for the wave is mainly from internal stores, suggesting that sperm-egg fusion at the egg surface activates the production of a Ca 2+ messenger, which in turn triggers Ca 2+ release from internal stores (Lee 1996 (Clapper et al. 1987) . At the time, it was fully expected that the Ca 2+ messenger generated during fertilization was IP 3 . This was because IP 3 was the only substance that was known to be capable of releasing Ca 2+ from internal stores.
Indeed, addition of IP 3 to the isolated egg microsomes elicited Ca 2+ release. In addition to IP 3 , NAD was also found to be able to release as much Ca 2+ . The kinetics of the release were, however, quite different. With IP 3 , the release was immediate, while a prominent delay was seen with NAD. This initial delay suggested that NAD may be enzymatically converted to an active form, accounting for the delay. This turned out to be the case and provided a way to produce enough active metabolite for identification (Clapper et al. 1987 , Lee et al. 1989 . The active metabolite from NAD was eventually purified and crystallized. X-ray diffraction studies showed that the active metabolite is a cyclic compound formed by linking the adenine ring of NAD to the terminal ribose ). The nicotinamide group, which normally attached to the terminal ribose is released during the enzymatic synthesis. The site of cyclization is at N1 of the adenine ring. This cyclization bond can be broken either chemically by heat or hydrolysed enzymatically. The hydrolysis product is ADPR. Because the active metabolite is cyclic and upon hydrolysis produces ADPR, it was named cyclic ADPribose (Lee et al. 1989) .
Using egg microsomes as an assay, it was found that, additionally, a derivative of NADP, with a nicotinic acid group replacing the nicotinamide group, was also able to release Ca 2+ from the microsomes. This compound was subsequently identified as nicotinic acid adenine dinucleotide phosphate (NAADP), which differs from NADP by only one mass unit . This small structural change gives it potent Ca 2+ releasing activity. Three critical determinants of Ca 2+ releasing activity of this molecule have been identified. They are the carboxyl group of the nicotinic acid moiety, the 2¢-phosphate and the amino group of the adenine ring. Any modifications of these determinants greatly reduce its calcium release activity . Cyclic ADP-ribose and NAADP can release Ca 2+ not only in vitro but are fully active inside live cells. This was shown convincingly using caged analogues of cADPR and NAADP. A UV-sensitive cage group is attached onto the 2¢-phosphate of NAADP ). As indicated above, the phosphate group is critical for the Ca 2+ releasing activity. Attaching the cage group makes the analogue biologically inactive. Exposure of the cage group to UV-light photolyses it and regenerates the biologically active NAADP. In the case of cADPR, the cage group was attached to one of the two phosphates . Again it is biologically inactive but can regenerate cADPR after exposure to UV. Sea urchin eggs loaded with caged cADPR and fluo 3 by microinjection produced elevated intracellular Ca 2+ when exposed to UV.
Similar results were obtained with caged NAADP.
As a control, eggs were injected with caged ATP and prolong UV exposure did not produce any Ca 2+ release. It is thus clear that both cADPR and NAADP are effective in mobilizing calcium stores in live cells. Work in the past decade has shown that both cADRP and NAADP are active in a wide variety of cells. In the case of cADPR, more than 48 different responsive cell types have so far been reported. They include more than 20 different species from three biological kingdoms, from protist to plant, and to animal (Lee 1997 . A specific antagonist of cADPR, 8-amino-cADPR, blocks the releasing effect of cADPR, but not NAADP (Walseth & Lee 1993 . NAADP was found to induce desensitization in the egg microsomes, and under this desensitized condition cADPR still remains active (Aarhus et al. 1996 , Genazzani et al. 1996 . These results indicate that three Ca 2+ release mechanisms are totally independent of each other. Accumulating evidence has indicated that the target of cADPR is the RyR. It has been demonstrated that the cADPR-sensitive channels reconstituted into lipid bilayers exhibit the characteristics similar to the RyRs (Lokuta et al. 1998 , Perez et al. 1998 . The cADPR-sensitive release mechanism, however, appears to be more complicated and involves other associated proteins. Calmodulin and FK506-binding protein (Noguchi et al. 1997 ) are such factors. Using a photoaffinity labelling technique, a protein of 140 kDa is also shown to be involved . The specific type of channel that NAADP activates is currently unknown. The intracellular stores that it acts on are, however, different and separable from the endoplasmic reticulum , 2000 . A recent report has provided evidence that the NAADP-sensitive stores in sea urchin eggs are acidic organelles similar to lysosomes (Churchill et al. 2002) .
The enzymatic production of cADPR and NAADP
Much is now known about the enzymology of cADPR and NAADP production. The enzyme that produces cADPR is called ADP-ribosyl cyclase, which cyclizes NAD to produce cADPR (Lee & Aarhus 1991) . In the process, nicotinamide, which is linked to the terminal ribose of NAD is released. The cyclase is a ubiquitous enzyme and three homologues have been identified. In Aplysia, it is a soluble protein of 30 kDa and contains 285 amino acids (Glick et al. 1991) . A membranebound lymphocyte antigen called CD38 has been identified as a mammalian homologue (States et al. 1992 , Howard et al. 1993 . Another homologue is an antigen called BST-1, which is a GPI-anchored protein (Itoh et al. 1994) . In the middle of all three proteins, there is a highly conserved sequence. Additionally, the 10 cysteines in the soluble cyclase can be perfectly aligned with the other two proteins. Overall, there is about 30% sequence identity among the three proteins (Lee 2000) . It is well characterized that cADPR is derived from NAD, while NAADP is from NADP. Surprisingly, ADPribosyl cyclase is responsible for the synthesis of both cADPR and NAADP . The reaction that leads to NAADP synthesis is a base-exchange reaction. In the presence of nicotinic acid, the cyclase or its homologue, CD38, catalyses the exchange of the nicotinamide group of NADP with nicotinic acid and produces NAADP. An important factor that controls the multiple reactions of this enzyme is pH. Under acidic conditions, the base-exchange reaction is in fact the dominant reaction catalysed by the soluble cyclase as well as CD38 (Lee 2000) .
The Aplysia cyclase has been recombinantly produced in yeast and crystallized (Prasad et al. 1996 , Munshi & Lee 1997 . This cyclase has also been co-crystallized with one of its substrates, nicotinamide. X-ray diffraction studies show that the nicotinamide binding site is in a pocket near the central cleft (Munshi et al. 1999) . The highly conserved sequence in the middle of the cyclase, in fact, forms part of the active site pocket. The critical residues at the active site have been identified by sitedirected mutagenesis. The glutamate 179 situated deep inside the pocket has been shown to be the catalytic residue. Any modification, even highly conservative substitution, renders the cyclase inactive. The nicotinamide is bound to the rim of pocket very close to tryptophan 140. There is another critical tryptophan that lines the other side of the rim of the pocket (Munshi et al. 1999) .
A unified catalytic model for the Aplysia cyclase and CD38 has been proposed (Lee 1999) . NAD is a long linear molecule. In order to cyclize it into cADPR, the enzyme must bind it and fold it into a ring such that the two ends are close enough to react. The two tryptophans at the active site pocket can serve such a function. The catalytic residue, glutamate 179 in the soluble cyclase or glutamate 226 in CD38 (Munshi et al. 1999 (Munshi et al. , 2000 can then attack and release the nicotinamide group, forming an intermediate. Apparently, both the cyclase and CD38 can bind either NAD or NADP in this folded conformation. This suggests that the active site does not recognize the 2¢-position. That is, the presence of a phosphate group at this position, as in the case of NADP, does not interfere with the binding of the substrate. What happens next depends on what is present. If no other nucleophiles are present, the N1 of the adenine ring reacts with the terminal ribose and form the cyclic product cADPR. If nicotinic acid is present, nucleophilic attack of the intermediate results in an exchange reaction and NAADP is produced. This reaction is most prominent at acidic pH.
Cyclic ADP-ribose has now been shown to be involved in the regulation of various cell functions in a variety of tissues or organs (Lee 1997 (Lee , 2001 ). In regard to muscle contraction, it is found that this cyclic nucleotide increases the Ca 2+ sensitivity of the cardiac RyRs reconstituted in bilayers (Meszaros et al. 1993) . A similar sensitizing effect of cADPR is also seen in the type 3 RyRs (Sonnleitner et al. 1998) as well as RyRs from smooth muscle . Functionally, cADPR has been shown to potentiate the calcium spark frequency in cardiac myocytes (Cui et al. 1999) , regulate Ach-induced calcium oscillation in tracheal smooth muscles (Prakash et al. 1998) , and modulate the spontaneous transient outward currents in VSMs (Cheung 2003) . In smooth muscle, cADPR has also been reported not only to mediate contraction but also modulate relaxation (Dipp & Evans 2001 , Barone et al. 2002 . In coronary arteries, cADPR is found to be involved in controlling vascular tone (Geiger et al. 2000) . The physiological role of NAADP in muscles has just begun to be investigated. It has been shown to be effective in mediating Ca 2+ signals and contraction in arterial smooth muscles via a novel two-pool mechanism (Boittin et al. 2002) . Whether it does function as a second messenger in the process requires further investigation.
Cyclic ADP-ribose-mediated activation of RyRs in the control of vascular tone (P. stores. In this regard, Kannan et al. (1996) reported that cADPR induces the SR Ca 2+ release in b-escin-permeabilized smooth muscle cells freshly isolated from porcine coronary arteries. In studies using a-toxin permeabilized cells, we found that cADPR produces Ca 2+ release in both cultured and freshly dissociated cow coronary and rat renal VSM cells. This cADPRinduced Ca 2+ release from the SR can be completely blocked by cADPR antagonist, 8-bromo-cADPR, but not by IP 3 R blockers. It is concluded that cADPR mobilizes intracellular Ca 2+ through a mechanism independent of IP 3 in VSM cells (Yu et al. 2000) . In the experiments using KCl to depolarize the cell membrane and consequently produce Ca 2+ influx- (Geiger et al. 2000 , Yu et al. 2000 .
Cyclic ADP-ribose signalling in control of vascular tone
In the isolated, perfused and pressurized small coronary arteries, we found that basic vascular tone or spontaneous tension can be developed during a 1. view has been further supported by the finding that OXO markedly enhances the activity of ADP-ribosylcyclase and increases the production of cADPR in cultured coronary VSM cells. It seems that ADP-ribosylcylcase is directly coupled to M 1 mAChRs. When these receptors are activated, the production of cADPR increases, whereby Ca 2+ is released from the SR through RyR (Ge et al. 2003) .
RyR activation by cADPR in VSM cells
Despite controversial findings, most studies have indicated that cADPR can activate RyR, producing Ca 2+ release from the SR or ER in different tissues or cells , Sitsapesan et al. 1994 , Lahouratate et al. 1997 (Hein et al. 2001 , Gloe et al. 2002 , Platts et al. 2002 Evidence for integrin involvement in the regulation of myogenic vascular tone
The most attractive experimental evidence for integrins in regulation of vasomotor tone, comes from studies demonstrating that synthetic peptides or fragments of ECM proteins that contain integrin-binding amino acid sequences are strongly vasoactive (Martinez-Lemus et al. 2003) . It is noteworthy that most integrins of VSM cells recognize the Asp-Gly-Asp (RGD) integrinbinding motif contained in many vascular wall ECM proteins, e.g. collagen, fibronectin and vitronectin. In previous work in our laboratory, we observed that isolated rat cremaster arterioles responded to RGDcontaining peptides with a transient constriction followed by a sustained dilation, whereas, control peptides containing Arg-Gly-Glu (RGE) did not (Mogford et al. 1996 , 1997 , D'Angelo et al. 1997 . We have also found that the dilation was endothelium-independent and that use of a cyclic form of RGD enhanced the vasodilatory potency, thereby implicating a v b 3 integrin involvement (Wu et al. 1998) . In support of this, a function blocking anti-b 3 integrin antibody attenuated the vasodilation to cyclic-RGD. Proteolysed fragments of type 1 collagen, which contain multiple exposed RGD residues, were observed to induce a vasodilation that was inhibited with the anti-b 3 integrin antibody. These observations suggest that antagonism of integrin receptors may cause vasodilation by inhibiting spontaneous myogenic tone (D'Angelo & Meininger 1994, Davis et al. 2000) . In addition to the RGD integrin recognition motif, two other integrin binding sequences may affect VSMC. These motifs include Asp-Gly-Glu-Ala (DGEA), which interacts with a 2 b 1 , and Leu-Asp-Val (LDV), which interacts with a 4 b 1 . To our knowledge, peptides containing the DGEA sequence have not been studied, but, we recently reported that LDV-containing peptides cause sustained constriction of rat cremaster arterioles. This constriction is endothelium-independent and blocked by an anti-a 4 integrin function-blocking antibody. More recently, studies from our laboratory indicate that the myogenic response to step increases in intravascular pressure is also inhibited by RGD containing peptides. In summary, the evidence to date is convincing for the involvement of various integrins of VSM cells in the control of myogenic vascular tone and the myogenic response , Hill et al. 2001 .
Integrin signalling through calcium entry and involvement of focal contact proteins
Additional rationale to support integrin involvement in the myogenic response has been based on overlap between calcium-signalling and integrin-signalling pathways in VSM cells (Hill et al. 2001 In arteriolar VSM cells, we have observed that engagement and clustering of a 5 b 1 integrins is required to produce the enhancement in L-type calcium current. We also observed that the enhancement of current was inhibited by PTK inhibitors and by a c-Src-specific inhibitory peptide or c-Src antibody implicating involvement of c-Src. Additional supportive observations have shown that enhancement of basal L-type current is obtained by intracellular application of constitutively active Src kinase or inhibition of tyrosine phosphatase. Antibodies to other components of the focal adhesion complex also interfere with a 5 b 1 regulation of calcium current (Wu et al. 1998 , 2001 , Hill et al. 2001 . For example, anti-FAK, anti-paxillin and antibodies to other focal adhesion or CSK proteins containing SH3 or SH2 domains all inhibit enhancement of calcium current following a 5 b 1 stimulation. The enhancement of basal L-type current by a 4 b 1 was also prevented by inhibition of Src family kinases. Collectively, these studies strongly implicated the importance of c-Src, and/or other protein tyrosine kinases and cytoskeletal proteins, which are linked to integrin signalling, in the regulation of L-type calcium channels in VSM cells .
Ca
2+ sparks and activation of plasma membrane K Ca channels in VSM cells (M. T. Nelson, University of Vermont Medical School)

2+ sparks
The discovery of temporally and spatially modulated Ca 2+ signals, including Ca 2+ sparks and waves, in smooth muscle , Jaggar et al. 2000 and in other cell types has radically altered the traditional view that the intracellular Ca 2+ concentration ([Ca 2+ ] i ) is homogeneously distributed within the cells (Fay et al. 1995 . There are a number of functional implications of this paradigm shift.
( (Nelson & Quayle 1995 , Faraci & Heistad 1998 , and is an important determinant of blood pressure (Brenner et al. 2000) . Ca 2+ sparks were first identified in cardiac muscle (Cheng et al. 1993) , and subsequently in skeletal (Klein et al. 1996) and smooth muscle (Cheng et al. 1993 , Cannell et al. 1995 . Although early measurements in urinary bladder smooth muscle (UBSM) by Ganitkevich & Isenberg (1992) showed that Ca 2+ currents activate ryanodine-sensitive Ca 2+ release, this process is remarkably different from that observed in cardiac muscle. CICR in UBSM is very slow, occurring over hundreds of milliseconds. Given that the spike of an action potential in UBSM is much shorter (about 20 ms) than this process, the contribution of CICR to muscle contraction in bladder is unclear, but likely provides, at best, only a fraction of the Ca 2+ for the transient. -10 6 -fold, resulting in K + efflux substantial enough to hyperpolarize the membrane potential by 10-20 mV.
Global
Further evidence for the regulation of BK channels by sparks is provided by the observation that inhibitors of Ca 2+ sparks and BK channels depolarize arterial smooth muscle in a non-additive manner. Ca 2+ sparks, through activation of BK channels, thus, function as a negative feedback element to limit membrane depolarization and contraction.
Roles of the BK channel b 1 -subunit
The BK channel in smooth muscle is composed of the a pore and b 1 -subunits. The b 1 -subunit is highly expressed in smooth muscle, but not in other tissues. The b 1 -subunit has been shown to increase the apparent Ca 2+ -sensitivity of the pore-forming a-subunit in heterologous expression systems. The important physiological role of the b 1 -subunit in smooth muscle is just emerging. Our recent studies also suggest that the coupling of Ca 2+ sparks to BK channels is decreased, and in some cases uncoupled, in smooth muscle cells from b 1 -KO mice (Brenner et al. 2000) . Furthermore, cerebral arteries are more constricted, and the b 1 -KO mouse exhibits elevated blood pressure and shows evidence of cardiac hypertrophy.
Modulation of the expression of the b 1 -subunit expression. Ablation of the b 1 -subunit gene of the BK channel leads to an elevation of blood pressure (Brenner et al. 2000) . The role of the b 1 -subunit has been also studied in the arteries from Ang II-induced hypertensive rats. All fast processes in the vasculature, which include vasoconstriction, secretion of vasorelaxants and vasoconstrictors, and a number of slower ones including proliferation, migration and apoptosis, are regulated by intracellular Ca 2+ . An important unresolved question is how fluctuations of the concentration of this inorganic ion can regulate a multitude of cellular processes (Chen & van Breemen 1992 , Daniel et al. 1995 , Lee et al. 2002a , 1997 , Daniel et al. 1995 , Lee et al. 2002a (Daniel et al. 1995 , Gurney et al. 2000 , Lee et al. 2002a , Daniel et al. 1995 , Lee et al. 2002a . Removal of external Na + would prevent the decline in MT Ca 2+ signal indicating that half of the mitochondria communicated with the PM NCX through the peripheral SR. In addition, a fraction of the mitochondrial population was able to take up Ca 2+ delivered by the reverse mode NCX, upon sudden removal of external Na + (Hajnoczky et al. 1995 , Gunter et al. 2000 , Pozzan et al. 2000 , Montero et al. 2001 Szado et al. 2003 ).
SR-mitochondrial junctions
In conclusion, we propose that junctional membrane complexes between the plasmamembrane, SR/ER and mitochondria play a crucial role in site-specific Ca 2+ signalling in the vasculature.
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